Assessment of urinary N-acetyl-β-D-glucosaminidase activity in geriatric cats with variable plasma creatinine concentrations with and without azotemia

American Journal of Veterinary Research

Volumn 71, Issue 2, 2010, Pages 241-247

  Jepson, Rosanne E ^a   Vallance, Charlene ^b   Syme, Harriet M ^a   Elliott, Jonathan ^c  

^a QUEEN MOTHER HOSPITAL FOR ANIMALS   (United Kingdom)

^b ROYAL VETERINARY COLLEGE   (United Kingdom)

^c WALTHAM CENTRE FOR PET NUTRITION   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; N ACETYL BETA GLUCOSAMINIDASE;

ANIMAL EXPERIMENT; ARTICLE; CAT; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; ENZYME ACTIVITY; FEMALE; MALE; MEASUREMENT; NONHUMAN; PROTEIN URINE LEVEL; PROTEINURIA; STORAGE TEMPERATURE; UREMIA;

ACETYLGLUCOSAMINIDASE; AGING; ANIMALS; AZOTEMIA; CAT DISEASES; CATS; COLORIMETRY; CREATININE; CROSS-SECTIONAL STUDIES; FEMALE; MALE;

ANIMALIA; FELIDAE;

EID: 77249176251     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.71.2.241     Document Type: Article

References (51)

1. Costigan MG, Rustom R, Bone JM, et al. Origin and significance of urinary N-acetyl-β,-D-glucosaminidase (NAG) in renal patients with proteinuria. Clin Chim Acta 1996;255:133-144.
2. Ikonne JU, Ellios RB. N-acetyl-β-D-hexosaminidase component A. Different forms in human tissues and fluids. Biochem J 1973;135:457-462.
3. Bourbouze R, Baumann F-C, Bonvalet J-P, et al. Distribution of N-acetyl-β-D-glucosaminidase isoenzymes along the rabbit nephron. Kidney Int 1984;25:636-642.
4. Robinson D, Stirling S. N-acetyl-β-D-glucosaminidase in human spleen. Biochem J 1968;107:321-327.
5. Paigen K, Peterson J. Coordinancy of lysosomal enzyme excretion in human urine. J Clin Invest 1978;61:751-762.
6. Sato R, Soeta S, Syuto B, et al. Urinary excretion of N-acetyl-β-D-glucosaminidase and its isoenzymes in cats with urinary disease. J Vet Med Sci 2002;64:367-371.
7. Ellis BG, Tucker SM, Thompson AE. Presence of serum and tissue forms of N-acetyl-β-D-glucosaminidase in urine from patients with renal disease. Clin Chim Acta 1975;64:195-202.
8. Tucker SM, Pierce RJ, Price RG. Characterization of human N-acetyl-β-D-glucosaminidase isoenzymes as an indicator of tissue damage in disease. Clin Chim Acta 1980;102:29-40.
9. Mandic LM, Acimovic JM, Jovanovic VB. The possibility of determining N-acetyl-β-glucosaminidase isoenzymes under alkaline conditions. Clin Biochem 2005;38:384-389.
10. Matteucci E, Pellegrini L, Uncini-Manganelli C, et al. More on effects of storage time and temperature on urinary enzymes: a 1-year study. Enzyme 1992;46:249-251.
11. Matteucci E, Gregori G, Pellegrini L, et al. How can storage time and temperature affect enzymatic activities in urine? Enzyme 1991;45:116-120.
12. Jung K, Priem F, Klotzek S, et al. Methods compared for determining activity of N-acetyl-β-D-glucosaminidase in urine without pretreatment of sample: different sensitivity and species effect. Enzyme 1991;45:215-221.
13. Herget-Rosenthal S, Poppen D, Hüsing J, et al. Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin Chem 2004;50:552-558.
14. Bosomworth MP, Aparicio S, Hay A, et al. Urine N-acetyl-β-D- glucosaminidase-a marker of tubular damage? Nephrol Dial Transplant 1999;14:620-626.
15. Lulich JP, Osborne CA, O'Brien TD, et al. Feline renal failure: questions, answers, questions. Compend Contin Educ Pract Vet 1992;14:127-152.
16. Syme HM, Markwell PJ, Pfeiffer D, et al. Survival of cats with naturally occurring chronic renal failure is related to severity of proteinuria. J Vet Intern Med 2006;20:528-535.
17. Ross LA, Finco DR. Relationship of selected clinical renal function tests to glomerular filtration rate and renal blood flow in cats. Am J Vet Res 1981;42:1704-1711.
18. DiBartola SP, Broome MR, Stein BS, et al. Effect of treatment of hyperthyroidism on renal function in cats. J Am Vet Med Assoc 1996;208:875-878.
19. Mathur S, Brown CA, Dietrich UM, et al. Evaluation of a technique of inducing hypertensive renal insufficiency in cats. Am J Vet Res 2004;65:1006-1013.
20. Uechi M, Uechi H, Nakayama T, et al. The circadian variation of urinary N-acetyl-β-D-glucosaminidase and γ-glutamyl-transpeptidase in clinically healthy cats. J Vet Med Sci 1998;60:1033-1034.
21. Lapointe C, Belanger MC, Dunn M, et al. N-acetyl-β-D-glucosaminidase index as an early biomarker for chronic kidney disease in cats with hyperthyroidism. J Vet Intern Med 2008;22:1103-1110.
22. Syme HM, Barber PJ, Markwell PJ, et al. Prevalence of systolic hypertension in cats with chronic renal failure at initial evaluation. J Am Vet Med Assoc 2002;220:1799-1804.
23. Elliott J. Staging chronic kidney disease. In: Elliott J, Grauer GF, eds. BSAVA manual of canine and feline nephrology and urology. 2nd ed. Haryana, India: Replika Press Pvt Ltd, 2007;163.
24. Noto A, Ogawa Y, Mori S, et al. Simple, rapid, spectrophotometry of urinary N-acetyl-β-D-glucosaminidase, with use of a new chromogenic substrate. Clin Chem 1983;29:1713-1716.
25. Konings CH, Mulder C. Effect of gel filtration on urinary N-acetyl-β-D-glucosaminidase activity measured by the m- cresolsulfonphthaleinyl procedure (lett). Clin Chem 1990;36:402-403.
26. Drake PL, Krieg E, Teass AW, et al. Two assays for urinary N-acetyl-β-D-glucosaminidase compared. Clin Chem 2002;48:1604-1605.
27. Morita A, Numata Y, Kosugi Y, et al. Stabilities of N-acetyl-β-D- glucosaminidase (NAG) isoenzymes in urine: advantages of NAG isoenzyme B measurement in clinical applications. Clin Chim Acta 1998;278:35-43.
28. Loeb WF, Das SR, Trout JR. The effect of erythritol on the stability of gamma-glutamyl transpeptidase and N-acetyl glucosaminidase in human urine. Toxicol Pathol 1997;25:264-267.
29. Wiland P, Szechinski J. Proximal tubule damage in patients treated with gentamicin or amikacin. Pol J Pharmacol 2003;2003:631-637.
30. Mandic L, Radmila M, Jelena A, et al. Change in the iso-enzyme profiles of urinary N-acetyl-beta-D-glucosaminidase in workers exposed to mercury. Toxicol Ind Health 2002;18:207-214.
31. Hong CY, Chia KS, Ling SL. Urinary protein excretion in type 2 diabetes with complications. J Diabetes Complications 2000;14:259-265.
32. Jung K, Pergande M, Schinrke E, et al. Urinary enzymes and low molecular mass proteins as indicators of diabetic nephropathy. Clin Chem 1988;34:544-547.
33. Mueller PW, Hall WD, Caudill SP, et al. An in-depth examination of the excretion of albumin and other sensitive markers of renal damage in mild hypertension. Am J Hypertens 1995;8:1072-1082.
34. Heiene R, Moe L, Molmen G. Calculation of urinary enzyme excretion, with renal structure and function in dogs with pyometra. Res Vet Sci 2001;70:129-137.
35. Palacio J, Liste F, Gascon M. Enzymuria as an index of renal damage in canine leishmaniasis. Vet Rec 1997;140:477-480.
36. Grauer GF, Greco DS, Behrend EN, et al. Estimation of quantitative enzymuria in dogs with gentamicin induced nephrotoxicosis using enzyme/creatinine ratios from spot urine samples. J Vet Intern Med 1995;9:324-327.
37. Fortes MAQR, Andriolo A, Ortiz V, et al. Effect of shock wave reapplication on urinary N-acetyl-beta-glucosamindase in canine kidney. Int Braz J Urol 2004;30:148-154.
38. Holdt-Lehmann B, Lehmann A, Korten G, et al. Diagnostic value of urinary alanine aminopeptidase and N-acetyl-β-D-glucosaminidase in comparison to α 1-microglobulin as a marker in evaluating tubular dysfunction in glomerulonephritis patients. Clin Chim Acta 2000;297:93-102.
39. Locatelli F, Marcelli D, Comelli M, et al. Proteinuria and blood pressure as causal components of progression to end stage renal disease. Nephrol Dial Transplant 1996;11:461-467.
40. Willnow TE, Nykjaer A, Herz J. Lipoprotein receptors: new roles for ancient proteins. Nat Cell Biol 1999;1:E157-E162.
41. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 1998;339:1448-1456.
42. Brenner BM. Nephron adaptation to renal injury or ablation. Am J Physiol 1985;249:F324-F337.
43. Hostetter TH, Olson JL, Rennke HG, et al. Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation. Am J Physiol 1981;241:F85-F92.
44. Wellwood JM, Price RG, Ellis BG, et al. A note on the practical aspects of the assay of N-acetyl-β-glucosaminidase in human urine. Clin Chim Acta 1976;69:85-91.
45. Tassi C, Mancuso F, Feligioni L, et al. Expression modes of urinary N-acetyl-β-D-glucosaminidase in patients with chronic renal insufficiency. Clin Chim Acta 2004;346:129-133.
46. Peterson ME, Gamble DA. Effect of nonthyroidal illness on serum thyroxine concentrations in cats: 494 cases (1988). J Am Vet Med Assoc 1990;197:1203-1208.
47. Tominaga M, Fujiyama K, Hoshino T, et al. Urinary N-acetyl-β-D- glucosaminidase in the patients with hyperthyroidism. Horm Metab Res 1989;21:438-440.
48. Adams LG, Polzin DJ, Osborne CA, et al. Influence of dietary protein/calorie intake on renal morphology and function in cats with 5/6 nephrectomy. Lab Invest 1994;70:347-357.
49. Finco DR, Brown SA, Brown CA, et al. Protein and calorie effects on progression of induced chronic renal failure in cats. Am J Vet Res 1998;59:575-582.
50. Elliott J, Rawlings JM, Markwell PJ, et al. Survival of cats with naturally occurring chronic renal failure: effect of dietary management. J Small Anim Pract 2000;41:235-242.
51. Ross SJ, Osborne CA, Kirk CA, et al. Clinical evaluation of dietary modification for treatment of spontaneous chronic kidney disease in cats. J Am Vet Med Assoc 2006;229:949-957.